If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
125.00    0.00 (0.00%)
Bid:
118.00
Ask:
124.50
Spread: 6.50 (5.508%)
Market Cap: £98.09m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Trading Update

12 Jan 2023 07:00

RNS Number : 4516M
Xaar PLC
12 January 2023
Β 

Β 

Β 

XAAR plcΒ 

Β 

TRADING UPDATE

Β 

Xaar plc ("Xaar", "the Group" or "the Company"), the leading inkjet printing technology group, today announces a trading update for the year ended 31 December 2022.

Β 

TRADING

Strong revenue growth and full-year profitability

Β· Revenue for the period is expected to be approximately Β£74 million (2021: Β£59.3 million), representing year on year growth of 24% driven by a combination of organic growth (9%) and acquisitions

Β 

Β· The Group is expected to deliver an on track adjusted profit for the year

Β 

Β· During 2022 the Group continued to invest in working capital and infrastructure development and in March completed the acquisition of Megnajet

Β 

Β 

Further operational and strategic progress

Β· Further progress was made throughout the year in implementing the strategy to achieve long-term profitable growth

Β 

Β· Successful launch of Aqueous printhead product in November 2022 as planned, and on budget, is receiving strong customer engagement

Β 

Β· Factory reorganisation commenced in December and is progressing well and on schedule for completion by March 2023. This project is expected to deliver increased efficiency, reduce power usage, and reduce costs

Β 

Β· The integration of recent acquisitions (FFEI and Megnajet) has been completed successfully and both are contributing positively to Group resultsΒ 

Β 

Β· Continued progress at EPS delivered its best performance to date with revenue growth of 36%

Β 

Β 

Challenging macro conditions expected to continue into 2023

Β· Sales volumes in the Printhead business continue to be affected by the uncertainty in China, which is expected to continue in the short term as Covid cases increase. At this stage it remains unclear when normal levels of business will return

Β 

Β· We have maintained our policy of increased investment in inventory to ensure availability of product during the factory reorganisation in Q1 2023 and the remainder of the year

Β 

BALANCE SHEET AND LIQUIDITY

Β· The Group remains well capitalised with a strong balance sheet with a net cash position as at 31 December 2022 of Β£8.6 million

Β 

Β 

John Mills, Chief Executive Officer, commented:

"I am hugely proud of the team in delivering a strong performance and making further progress with our strategy. We expect to deliver strong profitable revenue growth and the important milestone of achieving full year profitability representing great progress against our plan and remain well positioned for the business to achieve its exciting potential.

Aquinox has been successfully launched and is already being well received by our customers. With the operational improvements now well underway, notwithstanding the challenging external environment, the business is in good shape to continue to make further progress over the long term."

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Enquiries:

Β 

Xaar plc

+44 (0) 1223 423 663Β 

Ian Tichias, Chief Financial Officer

John Mills, Chief Executive Officer

Β 

Tulchan Communications

Giles Kernick

Olivia Lucas

+44 (0) 207 353 4200

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTSFIFWFEDSEDF
Date   Source Headline
13th Mar 200810:21 amRNSDividend Payment Date
13th Mar 20087:01 amRNSFinal Results
19th Feb 20087:00 amRNSNotice of Final Results
8th Feb 20087:00 amRNSCustomer product launch
30th Jan 20087:00 amRNSDirectorate Change
29th Jan 20087:01 amRNSControl change for partner
10th Jan 20087:01 amRNSYear end trading update
9th Jan 20087:00 amRNSHolding(s) in Company
4th Jan 20083:59 pmRNSTotal Voting Rights
2nd Jan 20089:53 amRNSHolding(s) in Company
11th Dec 200712:25 pmRNSHolding(s) in Company
6th Dec 20075:17 pmRNSTotal Voting Rights
30th Nov 200710:26 amRNSHolding(s) in Company
30th Nov 20077:00 amRNSHolding(s) in Company
27th Nov 200710:12 amRNSHolding(s) in Company
31st Oct 20078:30 amRNSHolding(s) in Company
17th Oct 20076:36 pmRNSHolding(s) in Company
15th Oct 20077:00 amRNSAppointment of Director
5th Oct 20075:46 pmRNSDirector/PDMR Shareholding
12th Sep 20077:01 amRNSInterim Results
11th Sep 20077:03 amRNSNew customer product launches
4th Sep 20075:39 pmRNSTotal Voting Rights
3rd Sep 20077:02 amRNSNotice of Interim Results
21st Aug 20075:29 pmRNSHolding(s) in Company
17th Aug 20076:00 pmRNSHolding(s) in Company
17th Aug 20075:40 pmRNSHolding(s) in Company
6th Aug 20077:00 amRNSDirector/PDMR Shareholding
2nd Aug 20074:30 pmRNSTotal Voting Rights
17th Jul 20077:00 amRNSAppointment of R&D Director
13th Jul 200711:05 amRNSHolding(s) in Company
11th Jul 20077:00 amRNSDirector/PDMR Shareholding
11th Jul 20077:00 amRNSTotal Voting Rights
10th Jul 20077:00 amRNSPeriod End Trading Statement
9th Jul 20075:45 pmBUSDutton Associates Announces Investment Opinion: Xaar Plc Rated Buy in Update Report by Dutton Associates
4th Jun 200710:51 amRNSHolding(s) in Company
24th May 20076:11 pmRNSDirector/PDMR Shareholding
24th May 20071:10 pmRNSHolding(s) in Company
23rd May 20077:00 amRNSFacility visit
16th May 20077:01 amRNSAppointment of Chairman
14th May 20077:00 amRNSDirector/PDMR Shareholding
10th May 20076:05 pmRNSDirector/PDMR Shareholding
9th May 20076:19 pmRNSDirector/PDMR Shareholding
1st May 20076:24 pmRNSDirector/PDMR Shareholding
1st May 200711:37 amRNSHolding(s) in Company
24th Apr 200710:20 amRNSDirector/PDMR Shareholding
23rd Apr 200712:56 pmRNSResult of AGM
23rd Apr 20077:01 amRNSAGM Trading Update
13th Apr 20075:00 pmBUSDutton Associates Announces Investment Opinion: Xaar plc Buy Rating Maintained In Update Coverage By Dutton Associates
11th Apr 200711:55 amRNSAnnual Information Update
29th Mar 20071:27 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.